LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, recently launched aPAP ClearPath™, a new ...
Anti–granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies predict complicated Crohn's disease (CD) years before signs or symptoms of the disease appear, according to new data. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback